Here are four recent cardiology procedures that were the first-of-their-kind or the first in the state they were performed in, as reported by Becker's: ...

The first-time integration of two innovative technologies is providing immediate benefits to Wyoming cardiac patients.

For a range of hospitalized patients at risk of worsening heart failure (HF), tying medical interventions to cardiac ...

The Farapulse PFA system provides a non-thermal approach for ablating heart tissue related to atrial fibrillation.

EY’s John Babbitt and Jim Welch join us for this episode to dive deeply into the Pulse of the Industry Report.

Boston Scientific Corporation BSX recently received the Pharmaceuticals and Medical Device Agency’s (“PMDA”) approval in ...

Mavacamten, a drug initially developed to treat hypertrophic cardiomyopathy, has shown signs of reducing heart stress in ...

Boston Scientific gets PDMA approval in Japan for FARAPULSE PFA System: Marlborough, Massachusetts Monday, September 30, 2024, 13:00 Hrs [IST] Boston Scientific Corporation, a glo ...

Taiwan and Hong Kong in early 2025 to study the safety and efficacy of concomitant procedures using the FARAPULSE PFA System ...